Statement of Organization, Functions, and Delegations of Authority, 62474-62475 [06-8869]
Download as PDF
<![CDATA[
62474
Federal Register / Vol. 71, No. 206 / Wednesday, October 25, 2006 / Notices
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Follow-up Study of Chronic Fatigue
Syndrome in Georgia—Reinstatement–
0920–0638—Coordinating Center for
Infectious Diseases (CCID), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
CDC is planning a follow-up study of
Chronic Fatigue Syndrome (CFS) in
metropolitan, urban and rural
communities in Georgia. This is in
response to Congressional
recommendations that the Centers for
Disease Control and Prevention (CDC)
sustain efforts to identify biomarkers for
CFS, educate health care providers
national and pilot regional provider
education programs designed to teach
health care providers how to evaluate,
diagnose and manage patients with CFS.
The proposed study builds on
information from the Georgia survey
with the objective of collecting clinical
information that will help in the
treatment of CFS and will help to
interpret results obtained from testing
biologic specimens (i.e., identify
biomarkers of CFS). This follow-up
study begins with a detailed telephone
interview of persons who participated
in the earlier survey and volunteered to
be contacted again. The interview is
similar (with minor modifications) to
the original interview and is intended to
obtain additional data on participant
health status during the last twelvemonth period. Eligible subjects with
CFS, other fatiguing illnesses, and well
controls will be asked to participate in
clinical evaluations.
about the diagnosis and treatment of
CFS, and better inform the public about
it to aid early detection and improve
patient care.
In 2004, OMB approved the
information collection, Survey of
Chronic Fatigue Syndrome and Chronic
Unwellness in Georgia, under OMB
Number 0920–0638. This study
provided baseline information on CFS
and other unexplained fatiguing illness
in metropolitan, urban, and rural
regions in Georgia. Data from the
proposed Follow-up Study of Chronic
Fatigue Syndrome in Georgia will be
used to describe the clinical course of
CFS and evaluate behavioral and
biochemical factors associated with
outcome. This follow-up study will also
determine access to and utilization of
health care by persons with CFS and
measure direct and indirect economic
burden due to the illness. As part of a
control strategy, the information from
this follow-up study will be used in
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Respondents
Number
responses
per
respondent
Average
burden per
response
(in hours)
Total
burden
hours
Telephone interview .........................................................................................
Clinical Evaluation ...........................................................................................
2,870
338
1
1
30/60
450/60
1,435
2,535
Total ..........................................................................................................
........................
........................
........................
3,970
Dated: October 19, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–17853 Filed 10–24–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on PROD1PC61 with NOTICES
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 71 FR 50065, dated
August 14, 2006), is amended to reflect
the establishment of the Healthy Aging
Program within the Division of Adult
and Community Health, National Center
for Chronic Disease Prevention and
VerDate Aug<31>2005
15:12 Oct 24, 2006
Jkt 211001
Health Promotion, Coordinating Center
for Health Promotion, Centers for
Disease Control and Prevention.
Section C–B, Organization and
Functions, is hereby amended as follow:
After the Office of the Director
(CUCE1), Division of Adult and
Community Health (CUCE) National
Center for Chronic Disease Prevention
and Health Promotion (CUC), insert the
following:
Healthy Aging Program (CUCE2). (1)
Serves as an active link between public
health and aging services networks to
provide leadership in health promotion
and disease prevention for older adults;
(2) provides scientific expertise and
rigor to health promoting strategies and
interventions through the use of data
and research; (3) disseminates
prevention messages, programs, and
policies; (4) contributes to the capacity
of systems and organizations to improve
the health of older adults; (5)
administers grants, cooperative
agreements, contracts, and other
procurement requests to implement
evidence-based health promotion
interventions and disseminates health
aging messages; (6) promotes expanding
prevention research for older adults by
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
supporting the Prevention Research
Centers Healthy Aging Research
Network (PRC–HAN); (7) administers
data into action through the
development of The State of Aging and
Health in America report series; (8)
collaborates with aging organizations to
expand the reach to professionals, the
public, and the media through the
development and evaluation of webbased health promotion modules and
media backgrounders on various older
adult health topics; and (9) directs and
disseminates the national public health
and action plan for brain health as part
of the Alzheimer’s disease segment of
the Healthy Aging Program.
Delete in its entirety the title and
functional statement for the Healthcare
and Aging Studies Branch (CUCEC), and
insert the following: Arthritis, Epilepsy
and Quality of Life Branch (CUCEC). (1)
Directs and supports activities that
increase the overall quality of life for
people affected by arthritis; (2) directs
and supports activities that improve
medical care, improve communication
and combat stigma, enhance selfmanagement, support surveillance and
prevention research, and increase public
awareness and knowledge about
E:\FR\FM\25OCN1.SGM
25OCN1
Federal Register / Vol. 71, No. 206 / Wednesday, October 25, 2006 / Notices
epilepsy; (3) directs and administers the
development of a national, state, and
local surveillance system of tracking
health-related quality of life (HRQOL)
among U.S. residents; (4) administers
grants, cooperative agreements,
contracts, and other procurement
requests to implement evidence-based
health promotion interventions and
disseminate arthritis prevention and
epilepsy education messages; (5)
develops, validates, and refines HRQOL
measure for use in tracking and
prevention research at each life stage;
(6) directs and coordinates the
evaluation of community and statebased intervention programs for arthritis
and epilepsy; (7) developes arthritis
epidemiology capacity and other
arthritis programmatic capabilities in
state health department settings; and (8)
disseminates health promotion and
disease prevention information through
national advocacy partners for arthritis
and epilepsy.
Dated: October 12, 2006.
William H. Gimson,
Chief Operating Officer, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 06–8869 Filed 10–24–06; 8:45 am]
BILLING CODE 4160–18–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2006F–0409]
Safe Foods Corporation; Filing of Food
Additive Petition
AGENCY:
Food and Drug Administration,
HHS.
mstockstill on PROD1PC61 with NOTICES
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that Safe Foods Corporation has filed a
petition proposing that the food additive
regulations be amended to expand the
conditions for the safe use of
cetylpyridinium chloride as an
antimicrobial agent in a pre-chiller or
post-chiller solution for application to
raw poultry carcasses.
DATES: Submit written or electronic
comments on the petitioner’s
environmental assessment by November
24, 2006.
ADDRESSES: Submit written comments
to the Division of Dockets Management
(HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
VerDate Aug<31>2005
15:12 Oct 24, 2006
Jkt 211001
1061, Rockville, MD 20852. Submit
electronic comments to https://
www.fda.gov/dockets/ecomments.
FOR FURTHER INFORMATION CONTACT:
Raphael Davy, Center for Food Safety
and Applied Nutrition (HFS–265), Food
and Drug Administration, 5100 Paint
Branch Pkwy., College Park, MD 20740,
301–436–1272.
SUPPLEMENTARY INFORMATION: Under the
Federal Food, Drug, and Cosmetic Act
(section 409(b)(5) (21 U.S.C. 348(b)(5))),
notice is given that a food additive
petition (FAP 6A4767) has been filed by
Safe Foods Corporation, c/o Keller and
Heckman LLP, 1001 G St. NW., suite
500 West, Washington, D.C. 20001. The
petition proposes to amend the food
additive regulations in § 173.375
Cetylpyridinium chloride (21 CFR
173.375) to expand the conditions for
the safe use of cetylpyridinium chloride
as an antimicrobial agent in a pre-chiller
or post-chiller solution for application
to raw poultry carcasses.
The potential environmental impact
of this action is being reviewed. To
encourage public participation
consistent with regulations issued under
the National Environmental Policy Act
(40 CFR 1501.4(b)), the agency is
placing the environmental assessment
submitted with the petition that is the
subject of this notice on public display
at the Division of Dockets Management
(see ADDRESSES) for public review and
comment. Interested persons may
submit to the Division of Dockets
Management written or electronic
comments by (see DATES). Two copies of
any written comments are to be
submitted, except that individuals may
submit one copy. Comments are to be
identified with the docket number
found in brackets in the heading of this
document. Received comments may be
seen in the Division of Dockets
Management between 9 a.m. and 4 p.m.,
Monday through Friday. FDA will also
place on public display any
amendments to, or comments on, the
petitioner’s environmental assessment
without further announcement in the
Federal Register. If, based on its review,
the agency finds that an environmental
impact statement is not required, and
this petition results in a regulation, the
notice of availability of the agency’s
finding of no significant impact and the
evidence supporting that finding will be
published with the regulation in the
Federal Register in accordance with 21
CFR 25.51(b).
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
62475
Dated: October 17, 2006.
Laura M. Tarantino,
Director, Office of Food Additive Safety,
Center for Food Safety and Applied Nutrition.
[FR Doc. E6–17834 Filed 10–24–06; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Health Resources
and Services Administration (HRSA)
publishes abstracts of information
collection requests under review by the
Office of Management and Budget
(OMB), in compliance with the
Paperwork Reduction Act of 1995 (44
U.S.C. Chapter 35). To request a copy of
the clearance requests submitted to
OMB for review, call the HRSA Reports
Clearance Office on (301)–443–1129.
The following request has been
submitted to the Office of Management
and Budget for review under the
Paperwork Reduction Act of 1995:
Proposed Project: Grants for Hospital
Construction and Modernization—
Federal Right of Recovery and Waiver
of Recovery (42 CFR Part 124, Subpart
H) (OMB No. 0915–0099Extension)
The regulation known as ‘‘Federal
Right of Recovery and Waiver of
Recovery,’’ provides a means for the
Federal Government to recover grant
funds and a method of calculating
interest when a grant-assisted facility
under Titles VI and XVI of the Public
Health Service Act is sold or leased, or
there is a change in use of the facility.
It also allows for a waiver of the right
of recovery under certain circumstances.
Facilities are required to provide written
notice to the Federal Government when
such a change occurs and to provide
copies of sales contracts, lease
agreements, estimates of current assets
and liabilities, value of equipment,
expected value of land on the new
owner’s books and remaining
depreciation for all fixed assets involved
in the transactions, and other
information and documents pertinent to
the change of status.
Estimates of annualized burden are as
follows:
E:\FR\FM\25OCN1.SGM
25OCN1
]]>Agencies
[Federal Register Volume 71, Number 206 (Wednesday, October 25, 2006)]
[Notices]
[Pages 62474-62475]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-8869]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 71 FR 50065, dated August 14, 2006), is
amended to reflect the establishment of the Healthy Aging Program
within the Division of Adult and Community Health, National Center for
Chronic Disease Prevention and Health Promotion, Coordinating Center
for Health Promotion, Centers for Disease Control and Prevention.
Section C-B, Organization and Functions, is hereby amended as
follow:
After the Office of the Director (CUCE1), Division of Adult and
Community Health (CUCE) National Center for Chronic Disease Prevention
and Health Promotion (CUC), insert the following:
Healthy Aging Program (CUCE2). (1) Serves as an active link between
public health and aging services networks to provide leadership in
health promotion and disease prevention for older adults; (2) provides
scientific expertise and rigor to health promoting strategies and
interventions through the use of data and research; (3) disseminates
prevention messages, programs, and policies; (4) contributes to the
capacity of systems and organizations to improve the health of older
adults; (5) administers grants, cooperative agreements, contracts, and
other procurement requests to implement evidence-based health promotion
interventions and disseminates health aging messages; (6) promotes
expanding prevention research for older adults by supporting the
Prevention Research Centers Healthy Aging Research Network (PRC-HAN);
(7) administers data into action through the development of The State
of Aging and Health in America report series; (8) collaborates with
aging organizations to expand the reach to professionals, the public,
and the media through the development and evaluation of web-based
health promotion modules and media backgrounders on various older adult
health topics; and (9) directs and disseminates the national public
health and action plan for brain health as part of the Alzheimer's
disease segment of the Healthy Aging Program.
Delete in its entirety the title and functional statement for the
Healthcare and Aging Studies Branch (CUCEC), and insert the following:
Arthritis, Epilepsy and Quality of Life Branch (CUCEC). (1) Directs and
supports activities that increase the overall quality of life for
people affected by arthritis; (2) directs and supports activities that
improve medical care, improve communication and combat stigma, enhance
self-management, support surveillance and prevention research, and
increase public awareness and knowledge about
[[Page 62475]]
epilepsy; (3) directs and administers the development of a national,
state, and local surveillance system of tracking health-related quality
of life (HRQOL) among U.S. residents; (4) administers grants,
cooperative agreements, contracts, and other procurement requests to
implement evidence-based health promotion interventions and disseminate
arthritis prevention and epilepsy education messages; (5) develops,
validates, and refines HRQOL measure for use in tracking and prevention
research at each life stage; (6) directs and coordinates the evaluation
of community and state-based intervention programs for arthritis and
epilepsy; (7) developes arthritis epidemiology capacity and other
arthritis programmatic capabilities in state health department
settings; and (8) disseminates health promotion and disease prevention
information through national advocacy partners for arthritis and
epilepsy.
Dated: October 12, 2006.
William H. Gimson,
Chief Operating Officer, Centers for Disease Control and Prevention
(CDC).
[FR Doc. 06-8869 Filed 10-24-06; 8:45 am]
BILLING CODE 4160-18-M
